Clinical Research Directory
Browse clinical research sites, groups, and studies.
Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma
Sponsor: Intergroupe Francophone du Myelome
Summary
The primary objective of the study is to evaluate at Day 1 Cycle 2, the detection sensitivity of the urinary monoclonal component on a spot urine sample, compared to the reference measurement on 24-hour urine, in patients with Multiple Myeloma.
Official title: Diagnostic Performance of Spot Urine Sample for the Monoclonal Components Detection in Patients With Multiple Myeloma RHU(M)M Random or H24 Urine in (Multiple) Myeloma
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
180
Start Date
2022-05-18
Completion Date
2027-05
Last Updated
2025-05-23
Healthy Volunteers
No
Conditions
Interventions
Detection of monoclonal component
Monoclonal component analysis by electrophoresis and immnuofixation on the urine sample from miction and 24h urine sample.
Locations (20)
Ch Annecy Genevois
Annecy, France
Centre Hospitalier William Morey
Chalon-sur-Saône, France
Centre Hospitalier Métropole de Savoie
Chambéry, France
CHU François Mitterand
Dijon, France
CH de Dunkerque
Dunkirk, France
CHD Vendée
La Roche-sur-Yon, France
Hopital Bicètre
Le Kremlin Bicètre, France
Ch Le Mans
Le Mans, France
CH de Lens
Lens, France
Hopital Claude Huriez-CHRU LILLE
Lille, France
Centre Hospitalier Lyon sud
Lyon, France
CHU de Montpellier
Montpellier, France
Hôpital E. MULLER
Mulhouse, France
CHRU Nantes
Nantes, France
CHU de Reims
Reims, France
Chu Pontchaillou
Rennes, France
CHU Toulouse
Toulouse, France
CHRU Bretonneau
Tours, France
CH Bretagne Atlantique Vannes et Auray-P.Chubert
Vannes, France
CH de Versailles
Versailles, France